Attend the National Research Symposium & Gluten-Free EXPO June 3-4, 2017 Register Today

We fight to improve the lives of all affected by celiac disease and non-celiac gluten/wheat sensitivity NOW

Partnership with ImmusanT to Promote Phase 2 Clinical Trial of Nexvax2®, A Promising Celiac Disease Treatment

ImmusanT, a Cambridge, MA-based biotechnology company, has announced that Nexvax2®, an immunotherapy drug designed to protect celiac disease patients from gluten exposure, has successfully completed a Phase 1b clinical trial and is advancing to a Phase 2 trial. Currently, strict, lifetime adherence to a gluten-free diet is the only disease management protocol for celiac disease […]

Celiac Disease Foundation Urges You to Contact Your Representatives About Preserving Critical Affordable Care Act Patient Protections

Celiac Disease Foundation has launched a new Legislative Action Center to empower you, your family, and your friends to quickly and easily contact your elected Representatives about issues of concern to the celiac disease and non-celiac wheat/gluten sensitive community. We are urging you to use the Legislative Action Center right now to demand that your […]

Proud Sponsors of Celiac Disease Foundation